Tenet Healthcare Corporation $THC Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP reduced its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 53.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,891 shares of the company’s stock after selling 2,202 shares during the period. GSA Capital Partners LLP’s holdings in Tenet Healthcare were worth $384,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Norges Bank acquired a new position in shares of Tenet Healthcare during the 2nd quarter worth approximately $206,981,000. Boston Partners lifted its position in shares of Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after acquiring an additional 1,104,500 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after acquiring an additional 624,125 shares during the last quarter. Holocene Advisors LP acquired a new position in Tenet Healthcare in the 2nd quarter valued at about $102,855,000. Finally, WCM Investment Management LLC boosted its stake in shares of Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Stock Down 0.2%

Shares of NYSE:THC opened at $237.13 on Thursday. The stock has a 50-day simple moving average of $204.26 and a 200-day simple moving average of $198.96. The stock has a market capitalization of $20.62 billion, a P/E ratio of 15.31, a PEG ratio of 1.16 and a beta of 1.44. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $240.83. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same period in the previous year, the company posted $3.44 earnings per share. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Buying and Selling

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.81% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on THC shares. Cantor Fitzgerald upped their price objective on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Raymond James Financial set a $245.00 price target on Tenet Healthcare in a research note on Wednesday, October 29th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $265.00 price target on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Barclays increased their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.